Marketing dimensions in the prescription pharmaceutical industry: a systematic literature review

References

• Ambady, N., & Krabbenhoft, M. A. (2006). The 30-sec sale, using thin-slice judgments to evaluate sales effectiveness. Journal of Consumer Psychology, 16, 4–13.
   Web of Science ®Google Scholar
• Andaleeb, S. S., & Tallman, R. F. (1996). Relationships of physicians with pharmaceutical sales representatives and pharmaceutical companies, an exploratory study. Health Marketing Quarterly, 13, 79–89.
   PubMedGoogle Scholar
• Angell, M. (2005). The truth about the drug companies (1st ed.). New York, NY: Random House.
   Google Scholar
• Antman, E. M., Lau, J., Kupelnick, B., Mosteller, F., & Chalmers, T. C. (1992). A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatment for myocardial infection. JAMA, 268, 240–248.
   PubMed Web of Science ®Google Scholar
• Avorn, J., Chen, M., & Hartley, R. (1982). Scientific versus commercial sources of influence on the prescribing behavior of physicians. American Journal of Medicine, 73, 4–8.
   PubMed Web of Science ®Google Scholar
• Azoulay, P. (2002). Do pharmaceutical sales respond to scientific evidence. Journal of Economics and Management Strategy, 11, 551–594.
   Web of Science ®Google Scholar
• Bain, J. S. (1956). Barriers to new competition (1st ed.). Cambridge: Harvard University Press.
   Google Scholar
• Beckman, T., & Davidson, W. R. (1967). Marketing (1st ed.). New York, NY: The Ronald Press.
   Google Scholar
• Berndt, E. R., Bui, L., Reiley, D., & Urban, G. (1995). The roles of marketing, product quality, and price competition in the growth and composition of the U.S. antiulcer drug industry. In T. F. Bresnahan & R. J. Gordon (Eds.), The economics of new goods, NBER studies in income and wealth, September (pp. 277–322). Chicago, IL: University of Chicago Press.
   Google Scholar
• Bijwaard, G. E., Janssena, M. C. W., & Maaslanda, E. (2008). Early mover advantages. An empirical analysis of European mobile phone markets. Telecommunications Policy, 32, 246–261.
   Web of Science ®Google Scholar
• Black, I., & Tagg, S. (2007). A grounded theory of doctors' information search behaviour. Implications for information provision, pharmaceutical market entry and development. Journal of Marketing Management, 23, 347–366.
   Google Scholar
• Blechschmidt, J. (2003). Der Arzneimittelmarkt in Deutschland, Handlungsbedarf aus der Herstellerperspektive. In Strategien für das Pharma-Management (pp. 15–21). Wiesbaden: Betriebswirtschaftlicher Verlag Dr. Th. Gabler GmbH.
   Google Scholar
• Bond, R. S., & Lean, D. F. (1977). Sales promotion and product differentiation in two prescription drug markets. Washington, DC: Federal Trade Commission.
   Google Scholar
• Boulding, W., & Staelin, R. (1990). Environment, market share, and market power. Management Science, 36, 1160–1177.
   Web of Science ®Google Scholar
• Bowman, D., & Gatignon, H. (1996). Order of entry as a moderator of the effect of the marketing-mix on market share. Marketing Science, 15, 222–242.
   Web of Science ®Google Scholar
• Brown, C. L., & Lattin, J. M. (1994). Investigating the relationship between time in the market and pioneering advantage. Management Science, 40, 1361–1369.
   Web of Science ®Google Scholar
• Castro, J. O., & Chrisman, J. J. (1995). Order of market entry, competitive strategy, and financial performance. Journal Business Research, 33, 165–177.
   Web of Science ®Google Scholar
• Chen, H. D. B., & Norman, C. V. (2007). Consumer responses to direct to consumer prescription drug advertising. International Journal of Pharmaceutical and Healthcare Marketing, 1, 276–289.
   Google Scholar
• Chintagunta, P. K., & Manchanda, P. (2004). Responsiveness of physician prescription behavior to salesforce effort. An individual level analysis. Marketing Letters, 15, 129–145.
   Web of Science ®Google Scholar
• Churchill, G. A., Ford, N. M., Hartley, S. W., & Walker, O. C. Jr. (1985). The determinants of salesperson performance. A meta-analysis. Journal of Marketing Research, 22, 103–118.
   Web of Science ®Google Scholar
• Cohen, J. (2007). The new Dutch health insurance system and its implications for pharmaceutical innovation. International Journal of Pharmaceutical and Healthcare Marketing, 1, 214–225.
   Google Scholar
• Cohen, J. B., & Basu, K. (1987). Alternative models of categorization, toward a contingent processing framework. The Journal of Consumer Research, 13, 445–472.
   Web of Science ®Google Scholar
• Comanor, W. S. (1986). The political economy of the pharmaceutical industry. Journal of Economic Literature, 24, 1178–1217.
   PubMed Web of Science ®Google Scholar
• Cooley, D. O. (2009). How did you find your physician. International Journal of Pharmaceutical and Healthcare Marketing, 3, 46–58.
   Google Scholar
• Cooper, R. G., & Kleinschmidt, E. J. (1993). Major new products, what distinguishes the winners in the chemical industry. Journal of Product Innovation Management, 10, 90–111.
   Web of Science ®Google Scholar
• Corstjens, M., Demeire, E., & Horowitz, I. (2005). New-product success in the pharmaceutical industry: how many bites at the cherry? Journal of Economics of Innovation and New Technology, 14, 319–331.
   Google Scholar
• Coscelli, A. (2000). The importance of doctors' and patients' preferences in the prescription decision. Journal of Industrial Economics, 48, 349–369.
   Web of Science ®Google Scholar
• Dao, T. D. (1984). Drug innovation and price competition. Managerial and Decision Economics, 5, 80–84.
   Google Scholar
• Darroch, J., & Miles, M. P. (2011). A research note on market creation in the pharmaceutical industry. Journal of Business Research, 64, 723–727.
   Web of Science ®Google Scholar
• Datamonitor. (2007). Incremental improvements and paradigm shifts in strategy are both necessary to boost productivity. Datamonitor, July.
   Google Scholar
• Ding, M., & Eliashberg, J. (2008). A dynamic competitive forecasting model incorporating dyadic decision making. Management Science, 54, 820–834.
   Web of Science ®Google Scholar
• Dogramatzis, D. (2002). Pharmaceutical marketing. A practical guide (1st ed.). Englewood, CO: Interpharm Press.
   Google Scholar
• Donohue, J. M., & Berndt, E. R. (2004). Effects of direct-to-consumer advertising on medication choice. The case of antidepressants. Journal of Public Policy and Marketing, 23, 115–127.
   Web of Science ®Google Scholar
• Elling, M. E., Fogle, H. J., McKhann, C. S., & Simon, C. (2002). Making more of pharma's sales force: Pharmaceutical companies have lost their focus on doctors. The key to higher sales is regaining it. The McKinsey Quarterly, 3, 87–95.
   Google Scholar
• Ellison, S. F., Griliches, Z., & Hausman, J. (1997). Characteristics of demand for pharmaceutical products: An examination of four cephalosporins. RAND Journal of Economics, 28, 426–446.
   PubMed Web of Science ®Google Scholar
• Flechter, K. (1989). Marketing strategy and planning in the UK pharmaceutical industry. Some preliminary findings. European Journal of Marketing, 24, 55–67.
   Google Scholar
• Gagnon, M. -A., & Lexchin, J. (2008). The cost of pushing pills: A new estimate of pharmaceutical promotion expenditures in the United States. PLoS Med, 5(1), e1, 10.1371/journal.pmed.0050001.
   PubMed Web of Science ®Google Scholar
• Gillis, C., Pitt, L., Robson, M. J., & Berthon, P. (1998). Communication in the salesperson/customer dyad. An empirical investigation. Marketing Intelligence & Planning, 16, 100–106.
   Google Scholar
• Glitz, B. (1997). The focus group technique in library research. An introduction. Bulletin of the Medical Library Association, 85, 385–390.
   PubMedGoogle Scholar
• Goetzinger, L., Park, J., Lee, Y. J., & Widdows, R. (2007). Value-driven consumer e-health information search behavior. International Journal of Pharmaceutical and Healthcare Marketing, 1, 128–142.
   Google Scholar
• Golder, P. N., & Tellis, G. J. (1993). Pioneer advantage, marketing logic or marketing legend. Journal of Marketing Research, 30, 158–170.
   Web of Science ®Google Scholar
• Gonül, F. F., Carter, F., Petrova, E., & Srinivasan, K. (2001). Promotion of prescription drugs and its impact on physician's choice behaviour. Journal of Marketing, 65, 79–90.
   Web of Science ®Google Scholar
• Greenhalgh, T., Glenn, R., Macfarlane, F., Bate, P., & Kyriakidou, O. (2004). Diffusion of innovations in service organizations. systematic review and recommendations. The Milbank Quarterly, 82, 581–629.
   PubMed Web of Science ®Google Scholar
• Groves, K. E. M., & Sketris, T. S. E. (2003). Prescription drug samples – Does this marketing strategy counteract policies for quality use of medicines. Journal of Clinical Pharmacy and Therapeutics, 28, 259–271.
   PubMed Web of Science ®Google Scholar
• Harms, F., Rohmann, S., Heinrich, M., Druener, M., & Trommsdorff, V. (2002). Innovative marketing – Direct to Consumer (DTC) or the new P's of marketing, challenges for pharmaceutical policies in the 21st century. Pharmaceuticals Policy and Law, 5, 135–149.
   Google Scholar
• Hauser, J. R., & Wernerfelt, B. (1990). An evaluation cost model of consideration sets. Journal of Consumer Research, 16, 393–408.
   Web of Science ®Google Scholar
• Henry J. Kaiser Family Foundation. (2004). Prescription drugs trends. Menlo Park, CA: Author.
   Google Scholar
• Hill, R. (1999). Is bigger better? Addressing the question of scale in the pharmaceutical industry. In Pharmaceutical Industry Dynamics, Decision Resources (Vol. 6, pp. 1–12). Waltham, Massachusetts: Spectrum.
   Google Scholar
• Hoch, S. J., & Deighton, J. (1989). Managing what consumers learn from experience. Journal of Marketing, 53, 1–20.
   Web of Science ®Google Scholar
• Hollon, M. F. (1999). Direct-to-consumer marketing of prescription drugs, creating consumer demand. Journal of the American Medical Association, 281, 382–384.
   PubMed Web of Science ®Google Scholar
• Huff, L. C., & Robinson, W. T. (1994). The impact of leadtime and years of competitive rivalry on pioneer market share advantages. Management Science, 40, 1370–1377.
   Web of Science ®Google Scholar
• Hunt, M. (1998). Direct-to-consumer advertising of prescription drugs. Paper prepared for the National Health Policy Forum, April, 1–17.
   Google Scholar
• Iizuka, T., & Zhe Jin, G. (2002). The effects of direct-to-consumer advertising in the prescription drug market. Abstract Academy Health Meeting. Retrieved from SSRN: http://ssrn.com/abstract = 365140 20, 481–496.
   Google Scholar
• Jaakkola, E., & Renko, M. (2007). Critical innovation characteristics influencing the acceptability of a new pharmaceutical product format. Journal of Marketing Management, 23, 327–346.
   Google Scholar
• Jaffe, R. S. (2000). Tactics add to your power when dealing with physicians. Journal of Health Care Compliance, 2, 11–15.
   Google Scholar
• James, T., Harden, A., Oakley, A., Oliver, S., & Sutcliffe, K. (2004). Integrating qualitative research with trials in systematic reviews. British Medical Journal, 328, 1010–1012.
   PubMed Web of Science ®Google Scholar
• Jarvis, L. (2001). Productivity of big pharma falls after consolidation. Chemical Market Reporter, 259, 5.
   Google Scholar
• Jonsson, B. (2001). Flat or monotonic pricing of pharmaceuticals. Practice and consequences. The European Journal of Health Economics (HEPAC), 2, 104–112.
   Google Scholar
• Kalyanaram, G. K. (2008). The order-of-entry effect in prescription (Rx) and over-the-counter (OTC) pharmaceutical drugs. International Journal of Pharmaceutical and Healthcare Marketing, 2, 35–46.
   Google Scholar
• Kalyanaram, G. K. (2009). The endogenous modeling of the effect of direct-to-consumer advertising in prescription drugs. International Journal of Pharmaceutical and Healthcare Marketing, 3, 137–148.
   Google Scholar
• Kalyanaram, G., Robinson, W. T., & Urban, G. L. (1995). Order of market entry: Established empirical generalizations emerging empirical generalizations and future research. Marketing Science, 14, 212–221.
   Web of Science ®Google Scholar
• Kalyanaram, G., & Urban, G. L. (1992). Dynamic effects of the order-of-entry on market share, trial penetration, and repeat purchases for frequently purchased consumer goods. Marketing, 11, 235–250.
   Web of Science ®Google Scholar
• Kardes, F. R., & Kalyanaram, G. (1992). Order-of-entry effects on consumer memory and judgment. Journal of Marketing Research, 29, 343–358.
   Web of Science ®Google Scholar
• Kerin, R. A., Rajan Varadarajan, P., & Peterson, R. A. (1992). First-mover advantage. A synthesis, conceptual framework, and research propositions. Journal of Marketing, 56, 33–52.
   Web of Science ®Google Scholar
• Kleijnen, J., & Knipschild, P. (1992). The comprehensiveness of medline and embase computer searches, searches for controlled trials of homoeopathy ascorbic acid for common cold and ginkgo biloba for cerebral insufficiency and intermittent claudication. Pharm Weekly, 14, 316–320.
   PubMed Web of Science ®Google Scholar
• Kotler, P. (1998). A generic concept of marketing. Marketing Management, April, 48–54.
   Google Scholar
• Kotler, P., & Keller, K. L. (2006). Marketing management 12e. Englewood, NJ: Pearson Prentice Hall.
   Google Scholar
• Kremer, S. T. M., Bijmolt, T. H. A., Leeflang, P. S. H., & Wieringa, J. E. (2008). Generalizations on the effectiveness of pharmaceutical promotional expenditures. International Journal of Research in Marketing, 25, 234–246.
   Web of Science ®Google Scholar
• Lambkin, M. (1988). Order-of-entry and performance in new markets. Strategic Management Journal, 9, 127–140.
   Web of Science ®Google Scholar
• Leeflang, P. S. H., & Wieringa, J. E. (2010). Modeling the effects of pharmaceutical marketing. Market Letter, 21, 121–133.
   Web of Science ®Google Scholar
• Leffler, K. B. (1981). Persuasion or information? The economics of prescription drug advertising. Journal of Law and Economics, 24, 45–74.
   Web of Science ®Google Scholar
• Lexchin, J. (2009a). CJEM and pharmaceutical advertisements. It's time for an end. Canadian Journal of Emergency Medicine (CJEM), 11, 375–379.
   Web of Science ®Google Scholar
• Lexchin, J. (2009b). Pricing of multiple dosage prescription medications. An Analysis of the ontario drug benefit formulary. Health Policy, 91, 142–147.
   PubMed Web of Science ®Google Scholar
• Lieberman, M. B., & Montgomery, D. B. (1988). First-mover advantages. Strategic Management Journal, 9, 41–58.
   Web of Science ®Google Scholar
• Lilien, G., & Yoon, E. (1990). The timing of competitive market entry. An exploratory study of new industrial products. Management Science, 36, 568–585.
   Web of Science ®Google Scholar
• Lilien, G., Rao, A. G., & Kalish, S. (1981). Bayesian estimation and control of detailing effort in a repeat purchase diffusion environment. Marketing Science, 36, 568–585.
   Google Scholar
• Li Wan Po, A. (1997). A practical guide to undertaking a systematic overview. The Pharmaceutical Journal, 258, 518–520.
   Google Scholar
• Lurie, N., Rich, E. C., Simpson, D. E., Meyer, J., Schiedermayer, D. L., Goodman, J. L., & Paul McKinney, W. (1990). Pharmaceutical representatives in academic medical centers. Interaction with faculty and housestaff. Journal of General Internal Medicine, 5, 240–243.
   PubMed Web of Science ®Google Scholar
• Lynch, J., & de Chernatony, L. (2007). Winning hearts and minds, business-to-business branding and the role of the salesperson. Journal of Marketing Management, 23, 123–135.
   Google Scholar
• Manchanda, P., & Honka, E. (2005). The effects and role of direct-to-physician marketing in the pharmaceutical industry. An integrative review. Yale Journal of Health Policy, Law, and Ethics, 5, 785–822.
   PubMedGoogle Scholar
• Manchanda, P., Wittink, D. R., Ching, A., Cleanthous, P., Ding, M., Dong, X. J., … Xie, Y. (2005). Understanding firm, physician and customer choice behavior in the pharmaceutical industry. Marketing Letters, 16, 293–308.
   Web of Science ®Google Scholar
• Mintzes, B. (2002). Direct to consumer advertising is medicalising normal human experience. British Medical Journal, 324, 908–911.
   PubMed Web of Science ®Google Scholar
• Mitchell, W. (1989). Whether and when? Probability and timing of incumbents' entry into emerging industrial subfields. Administrative Science Quarterly, 34, 208–230.
   Web of Science ®Google Scholar
• Mizik, N., & Jacobson, R. (2004). Are physicians easy marks? Quantifying the effects of detailing and sampling on new prescriptions. Management Science, 50, 1704–1715.
   Web of Science ®Google Scholar
• Moher, D., Tetzlaff, J., Tricco, A. C., Sampson, M., & Altman, D. G. (2007). Epidemiology and reporting characteristics of systematic reviews. Plosmedicine, 4, 447–450.
   Google Scholar
• Mulrow, C. D., Cook, D. J., & Davidoff, F. (1997). Systematic reviews, critical links in the great chain of evidence. Annals of Internal Medicine, 126, 389–391.
   PubMed Web of Science ®Google Scholar
• Narayanan, S., Desiraju, R., & Chintagunta, P. K. (2004). Return on investment implications for pharmaceutical promotional expenditures. The role of marketing-mix interactions. Journal of Marketing, 68, 90–105.
   Web of Science ®Google Scholar
• Nichols, N. A. (1994). Scientific management at Merck. An interview with CFO Judy Lewent. Harvard Business Review, 91, 53–64.
   Google Scholar
• Parsons, L. J., & Abeele, P. V. (1981). Analysis of sales call effectiveness. Journal of Marketing Research, 18, 107–113.
   Web of Science ®Google Scholar
• Petticrew, M. (2006). Systematic reviews in the social sciences (1st ed.). Oxford: Blackwell Publishing.
   Google Scholar
• Rice, J. L. (2009). Are HMO physicians more price sensitive in prescribing brand-name drugs. International Journal of Pharmaceutical and Healthcare Marketing, 3, 184–209.
   Google Scholar
• Rizzo, J. A. (1999). Advertising and competition in the ethical pharmaceutical industry. The case of antihypertensive drugs. Journal of Law and Economics, 42, 89–116.
   Web of Science ®Google Scholar
• Robinson, W. T., & Fornell, C. (1985). Sources of market pioneer advantages in consumer goods industries. Journal of Marketing Research, 22, 305–317.
   Web of Science ®Google Scholar
• Rod, M., Ashill, N. J., & Carruthers, J. (2007). Pharmaceutical marketing return-on-investment. A European perspective. International Journal of Pharmaceutical and Healthcare Marketing, 1, 174–189.
   Google Scholar
• Rodríguez-Pinto, J., Rodríguez-Escudero, A. I., & Gutiérrez-Cillán, J. (2008). Order, positioning, scope and outcomes of market entry. Industrial Marketing Management, 37, 154–166.
   Web of Science ®Google Scholar
• Ruffolo, R. R. (2004). R&D productivity. A new way of working at Wyeth. American Pharmaceutical Review, 7, 105–107.
   Google Scholar
• Saxe, R., & Weitz, B. A. (1982). The SOCO scale. A measure of the customer orientation of sales people. Journal of Marketing Research, 19, 343–351.
   Web of Science ®Google Scholar
• Schmalensee, R. (1982). Product differentiation advantages of pioneering brands. American Economic Review, 72, 349–365.
   Web of Science ®Google Scholar
• Schulenburg, M., Kulp, W., & Greiner, W. (2003). Gesundheitsreformen in Deutschland, Aktuelle Entwicklungen und die vierte Hürde, Strategien für das Pharma-Management (pp. 23–52). Wiesbaden: Betriebswirtschaftlicher Verlag Dr, Th, Gabler GmbH.
   Google Scholar
• Schwartz, R., Soumerai, S. B., & Avorn, J. (1989). Physician motivations for nonscientific drug prescribing. Social Science and Medicine, 28, 577–582.
   PubMed Web of Science ®Google Scholar
• Shankar, V. (1997). Pioneers' marketing-mix reactions to entry in different competitive game structures. Theoretical analysis and empirical illustration. Marketing Science, 16, 271–293.
   Web of Science ®Google Scholar
• Shankar, V., Carpenter, G. S., & Krishnamurthi, L. (1998). Late mover advantage. How innovative late entrants outsell pioneers. Journal of Marketing Research, 35, 54–70.
   Web of Science ®Google Scholar
• Sharp, B., & Dawes, J. (2001). What is differentiation and how does it work. Journal of Marketing Management, 17, 739–759.
   Google Scholar
• Shaw, A. (2008). Direct-to-Consumer Advertising (DTC) of pharmaceuticals. ProQuest Discovery Guides, March.
   Google Scholar
• Shojania, K. G., Sampson, M., Ansari, M. T., Ji, J., Doucette, S., & Moher, D. (2007). How quickly do systematic reviews go out of date? A survival analysis. Annals of Internal Medicine, 147, 224–233.
   PubMed Web of Science ®Google Scholar
• Smith, M. C. (1983). The principles of pharmaceutical marketing. Binghamton, NY: Haworth Press.
   Google Scholar
• Solomon, L. (2007). Scored tablets make pill splitting easier. American Journal of Managed Care, e4, 1.
   Google Scholar
• Stremersch, S. (2008). Health and marketing. The emergence of a new field of research. International Journal of Research in Marketing, 25, 229–233.
   Web of Science ®Google Scholar
• Stremersch, S., & Van Dyck, W. (2009). Marketing of the life sciences. A new framework and research agenda for a nascent field. Journal of Marketing, 73, 4–30.
   Web of Science ®Google Scholar
• Subhash, J. C. (2009). Marketing, planning and strategy (8th ed.). Worcester: Custom Publishing.
   Google Scholar
• Szymanski, D. M., Troy, L. C., & Bharadwaj, S. G. (1995). Order-of-entry and business performance. An empirical synthesis and reexamination. Journal of Marketing, 59, 17–33.
   Web of Science ®Google Scholar
• Tellis, G. J., & Golder, P. N. (1996). First to market, first to fail? Real causes of enduring market leadership. MIT Sloan Management Review, 37, 65–75.
   Web of Science ®Google Scholar
• Trim, P., & Pan, H. (2005). A new product launch strategy NPLS model for pharmaceutical companies. European Business Review, 17, 325–339.
   Google Scholar
• Urban, G. L., Carter, T., Gaskin, S., & Mucha, Z. (1986). Market share rewards to pioneering brands. An empirical analysis and strategic implications. Management Science, 32, 645–659.
   Web of Science ®Google Scholar
• Vakratsas, D., & Kolsarici, C. (2008). A dual-market diffusion model for a new prescription pharmaceutical. International Journal of Research in Marketing, 25, 282–293.
   Web of Science ®Google Scholar
• Venkataraman, S., & Stremersch, S. (2007). The debate on influencing doctors' decisions. Are drug characteristics the missing link. Management Science, 53, 1688–1701.
   Web of Science ®Google Scholar
• White, H. J., Draves, L. P., Soong, R., & Moore, C. (2004). Ask your doctor! Measuring the effect of direct-to-consumer communications in the world's largest healthcare market. Journal of Advertising, 23, 53–68.
   Google Scholar
• Whitlock, E. J., Lin, J. S., Chou, R., Shekelle, P., & Robinson, K. A. (2008). Using existing systematic reviews in complex systematic reviews. Annals of Internal Medicine, 148, 776–782.
   PubMed Web of Science ®Google Scholar
• Wittink, D. R. (2003). Never put profit at risk. Canadian Pharmaceutical Marketing, Summer 27–29.
   Google Scholar
• Wong-Rieger, D. (2009). Should Canada allow direct-to-consumer advertising of prescription drugs. Canadian Family Physician, 55, 130–132.
   PubMed Web of Science ®Google Scholar